Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BDR who wrote (983)	9/8/1998 1:38:00 PM
From: VLAD	of 1016

Dale, CCSI was a joke from day one but I dare not short it in a manipulated market. The only thing to look at with CCSI was its ability to generate significant income on their bilirubin tests and it just ain't there. Sure they might make a few bucks but nothing significant. On the other hand you must give Vivus some credit. With no experience in manufacturing and marketing they were able to have the number one urological drug in the US last year which in the Viagra wake seems to be all but forgotton. We will see just how well Vivus' income is over the next 6 months. Foreign doctors are not under the pressure by HMOS to be "Cost efficient" doctors.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next